Search Orphan Drug Designations and Approvals
-
Generic Name: | Recombinant secretory leucocyte protease inhibitor |
---|---|
Date Designated: | 03/29/1991 |
Orphan Designation: | Treatment of congenital alpha-1 antitrypsin deficiency. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Amgen Inc. 3200 Walnut Street Boulder, Colorado 80301 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-